| Literature DB >> 20376338 |
Chantelle Garritty1, Alexander Tsertsvadze, Andrea C Tricco, Margaret Sampson, David Moher.
Abstract
BACKGROUND: Systematic reviews (SRs) should be up to date to maintain their importance in informing healthcare policy and practice. However, little guidance is available about when and how to update SRs. Moreover, the updating policies and practices of organizations that commission or produce SRs are unclear. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2010 PMID: 20376338 PMCID: PMC2848577 DOI: 10.1371/journal.pone.0009914
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Updating Survey Flow Diagram.
Organization Responses by Country.
| Country | N of Respondents; % |
| United Kingdom | 35/114; 30.7% |
| United States | 15/114; 13.1% |
| Canada | 11/114; 9.6% |
| Australia | 10/114; 8.7% |
| Netherlands | 5/114; 4.4% |
| Spain | 4/114; 3.5% |
| Brazil | 3/114; 2.6% |
| Denmark | 3/114; 2.6% |
| Finland | 3/114; 2.6% |
| Germany | 3/114; 2.6% |
| Italy | 3/114; 2.6% |
| New Zealand | 3/114; 2.6% |
| Switzerland | 3/114; 2.6% |
| Argentina | 1/114; 0.9% |
| Austria | 1/114; 0.9% |
| Belgium | 1/114; 0.9% |
| France | 1/114; 0.9% |
| Hong Kong | 1/114; 0.9% |
| Latvia | 1/114; 0.9% |
| Malaysia | 1/114; 0.9% |
| Mexico | 1/114; 0.9% |
| Norway | 1/114; 0.9% |
| Poland | 1/114; 0.9% |
| Portugal | 1/114; 0.9% |
| Romania | 1/114; 0.9% |
| Taiwan | 1/114; 0.9% |
*Percentages rounded to 1st decimal point.
Organization General Demographics.
| Characteristics of Respondent Organizations: | N of Respondents; % | |
|
| Producers of SRs | 75/107; 70% |
| Funders of SRs | 5/107; 5% | |
| Both Funders & Producers | 27/107; 25% | |
|
| Not-for profit | 96/100; 96% |
| For profit | 4/100; 4% | |
|
| Academic Institution | 40/100; 40% |
| National Government Agency | 21/100; 21% | |
| Regional/Local Government Agency | 7/100; 7% | |
| Private Organization | 4/100; 4% | |
| Medical Specialty Society | 4/100; 4% | |
| Managed Care Organization | 0/100; 0% | |
| Disease Specific Society | 0/100; 0% | |
| Other | 24/100; 0% | |
|
| Industry/Private Sector | 16/100; 16% |
| Government Grants | 85/100; 85% | |
| Non-profit (academic; non-governmental) | 49/100; 49% | |
| Endowment fund | 4/100; 4% | |
| Internal Institutional Funds | 17/100; 17% | |
| Other | 9/100; 9% | |
|
| ≤$10,000 USD | 26/85; 31% |
| $11,000–40,000 USD | 12/85; 14% | |
| $41,000–100,000 USD | 12/85; 14% | |
| $100,000–$200,000 USD | 6/85; 7% | |
| $200,000–$500,000 USD | 4/85; 5% | |
| >$500,000 USD | 0/85; 0% | |
|
| ≤10% | 32/97; 33% |
| 11–40% | 42/97; 43% | |
| 41–70% | 7/97; 7% | |
| 71–100% | 5/97; 5% | |
| Not sure | 4/97; 4% | |
| Not applicable | 7/97; 7% | |
*For several of the above characteristics, participants were asked to “check all that apply” thus certain totals/percentages do not add up to 100. Percentages rounded to the nearest whole number.
Figure 2Organizational Involvement in Evidence Synthesis (n = 114).
Respondent General Demographics.
| Characteristics of Participant Respondents: | N of Respondents; % | |
|
| Lead Author | 59/100; 59% |
| Co-author | 70/100; 70% | |
| Information Specialist | 8/100; 8% | |
| Statistician | 3/100; 3% | |
| Methodologist/Epidemiologist | 41/100; 41% | |
| Clinical Expert | 15/100; 15% | |
| Editor | 45/100; 45% | |
| Project Manager/Coordinator | 61/100; 61% | |
| None | 3/100; 3% | |
| Other Research Capacity | 11/100; 11% | |
|
| University-level training | 46/100; 46% |
| Continuing Education course(s) | 41/100; 41% | |
| Workshop training | 69/100; 69% | |
| Lecture(s) | 50/100; 50% | |
| No formal training | 8/100; 8% | |
| Other | 12/100; 12% | |
*For several of the above characteristics, participants were asked to “check all that apply” thus certain totals/percentages do not add up to 100. Percentages rounded to the nearest whole number.
Factors that Impact on Determining ‘When’ to Update.
| Factors impacting ‘when’ to update: | N of Respondents; % |
| Formal request from a policy or healthcare decision maker | 80/99; 81% |
| Number of new studies identified | 77/100; 77% |
| Totality (comprehensiveness) of all new evidence or data including harms & benefits | 75/99; 76% |
| Reporting of serious or ‘new’ serious adverse events | 74/100; 74% |
| Time credibility | 69/96; 72% |
| New inclusion criteria (outcomes; interventions; populations; methodological advances/new analysis) | 59/93; 63% |
| Need for an internal organizational decision | 52/92; 57% |
| Number of participants in new studies | 44/96; 46% |
*Percentages rounded to the nearest whole number.
Update Methods/Procedures.
| Update methods/procedures: | Use (always, often or sometimes)/N of respondents; % | Use (seldom or never)/N of respondents; % |
| Time specific approach | 66/99; 67% | 26/99; 26% |
| Bibliometric database entry-date searching | 37/98; 38% | 46/98; 47% |
| Editorial strategy with an algorithm of actions | 25/99; 25% | 61/99; 62% |
| Cumulative meta-analysis (or extensions) | 11/99; 11% | 68/99; 69% |
| Barrowman's identifying the ‘null’ diagnostic test | 4/99; 4% | 77/99; 78% |
*Percentages rounded to the nearest whole number.
Figure 3Types of Updating Action (n = 101).
Major/Moderate Benefits to Harmonization of Updating.
| Benefits to harmonization: | N of respondents; % |
| Use of existing resources more efficiently | 79/101; 78% |
| Access to new information, ideas, materials or other resources | 79/101; 78% |
| Potential to minimize duplication of services | 77/101; 77% |
| Ability to address issues beyond a single organization's domain | 62/100; 62% |
| Share responsibility across organizations for complex/controversial issues | 54/99; 55% |
*Percentages rounded to the nearest whole number.
Figure 4Major/Moderate Barriers to International Harmonization of Updating Efforts (n = 97).
Sensitivity Analysis of Cochrane Review Groups (CRGs) versus Other Organizations.
| Variables | CRGs % (n) | Non-CRGs % (n) | Absolute Differences (%) | 95% Confidence Intervals | |
|
| 94.3% (33/35) | 97.2% (70/72) | −2.9% | −16%, | 5.0% |
|
| 97.1% (34/35) | 69.4% (50/72) | 27.7% | −12.7%, | 39.3% |
|
| 97.1% (33/34) | 37.5% (27/72) | 59.6% | −42.9%, | 70.1% |
|
| |||||
| Updates Regularly | 61.8% (21/34) | 20.0% (14/70) | 41.8% | −21.9%, | 58.0% |
| Updates Irregular | 38.2% (13/34) | 70.0% (49/70) | −31.8% | −48.9%, | −11.4% |
| Does Not Update | 0% (0/34) | 10.0% (7/70) | −10.0% | −19.2%, | 1.4% |
|
| |||||
| Funders | 0% (0/29) | 25.0% (16/64) | −25.0% | −36.8%, | −10.3% |
| Authors | 86.2% (25/29) | 26.6% (17/64) | 59.6% | 39.1%, | 72.1% |
| Information Specialists | 0% (0/29) | 3.1% (2/64) | −3.1% | −10.7%, | 8.8% |
| Policy-makers | 3.4% (1/29) | 20.3% (13/64) | −16.9% | −28.6%, | −1.0% |
| All Combined | 10.3% (3/29) | 25.0% (16/64) | −14.7% | −28.3%, | 3.7% |
|
| 84.8% (28/33) | 61.3% (38/62) | 23.5% | 4.3%, | 38.6% |
|
| |||||
| Monthly searching | 6.7% (1/15) | 27.8% (5/18) | −21.1% | −44.9%, | 6.6% |
| Every 6 mos searching | 26.7% (4/15) | 22.2% (4/18) | 4.5% | −23.4%, | 33.0% |
| Every 12 mos searching | 26.7% (4/15) | 44.4% (8/18) | −17.7% | −44.7%, | 14.4% |
| Every 18 mos searching | 40.0% (6/15) | 5.6% (1/18) | 34.4% | 5.9%, | 59.1% |
|
| |||||
| Same Search Found in the Original SR | 96.0% (24/25) | 83.3% (30/36) | 12.7% | −5.2%, | 28.2% |
| Modified Search | 100% (23/23) | 97.0% (32/33) | 3.0% | −11.5%, | 15.3% |
| New Search | 43.8% (7/16) | 45.2 (14/31) | −1.4% | −28.2%, | 26.7% |
|
| |||||
| General Literature Searches | 100% (32/32) | 74.2% (49/66) | 25.8% | 11.8%, | 37.4% |
| Automatic Database Alerts | 60.0% (18/30) | 66.7% (40/60) | −6.7% | −27.3%, | 13.2% |
| Monitoring Trials Registries | 77.8% (21/27) | 45.2% (28/62) | 32.6% | 10.4%, | 49.1% |
| Statistical Approaches | 3.7% (1/27) | 17.2% (10/58) | −13.5% | −25.6%, | 2.9% |
| Monitoring Systematic Reviews | 64.3% (18/28) | 75.0% (48/64) | −10.7% | −31.2%, | 8.4% |
| Monitoring CPGs and/or HTAs | 60.0% (18/30) | 74.6% (47/63) | −14.6% | −34.5%, | 4.9% |
| Contacting Experts in the Field | 65.6% (21/32) | 77.8% (49/63) | −12.2% | −31.4%, | 6.1% |
|
| 81.3% (26/32) | 72.6% (45/62) | 8.7% | −10.4%, | 24.3% |
|
| 100% (31/31) | 86.4% (57/66) | 13.6% | 0.9%, | 23.9% |
|
| |||||
| Time-specific | 96.8% (30/31) | 59.0% (36/61) | 37.8% | 20.5%, | 50.6% |
| Editorial Strategy | 39.3% (11/28) | 24.1% (14/58) | 15.2% | −4.9%, | 35.6% |
| Entry Date Searching | 33.3% (8/24) | 49.2% (29/59) | −15.9% | −35.6%, | 7.6% |
| Cumulative Meta-analyses (CMA) | 4.0% (1/25) | 18.5% (10/54) | −14.5% | −27.3%, | 3.0% |
|
| |||||
| Changes Required to the Original Search Strategy | 30.4% (7/23) | 31.0% (18/58) | −0.6% | −20.2%, | 22.3% |
| Changes Required to the Screening Criteria | 50.0% (12/24) | 33.3% (19/57) | 16.7% | −6%, | 38.2% |
| Need to Re-do Data Extraction | 62.5% (15/24) | 50.9% (29/57) | 11.6% | −11.8%, | 32.3% |
| Need to Re-do Quality Assessment | 58.3% (14/24) | 42.1 (24/57) | 16.2% | −7.2%, | 37.2% |
|
| |||||
| Updating Methodologies | 10.3% (3/29) | 24.6% (16/65) | −14.3% | −27.8%, | 4.1% |
| Funding Resources | 67.7% (21/31) | 77.3% (51/66) | −9.6% | −29.1%, | 8.3% |
| Redundancy of Updating (Motivation Level of Reviewers) | 100% (30/30) | 39.0% (23/59) | 61.0% | 44%, | 72.4% |
| Limited Academic Credit | 60.0% (18/30) | 48.4% (31/64) | 11.6% | −9.8%, | 31.0% |
| Limited Publishing Formats | 33.3% (9/27) | 42.6% (26/61) | −9.3% | −28.6%, | 12.8% |
| Having to Updating SRs Completed by Others | 60.0% (15/25) | 33.9% (20/56) | 26.1% | 1%, | 44.3% |
|
| 66.7% (18/27) | 80.0% (52/65) | −13.3% | −33.8%, | 5.2% |
|
| |||||
| Access to New Information, Ideas, Materials or Other Resources | 88.5% (23/26) | 83.6% (56/67) | 4.9% | −13.9%, | 17.9% |
| Potential to Minimize Duplication of Services | 76.9% (20/26) | 85.1% (57/67) | −8.2% | −28.2%, | 7.8% |
| Use of Existing Resources More Efficiently | 80.8% (21/26) | 87.9% (58/66) | −7.1% | −26.7%, | 7.6% |
| Ability to Address Issues Beyond a Single Organization's Domain | 64.0% (16/25) | 70.8% (46/65) | −6.8% | −28.5%, | 13.0% |
| Shared Responsibility Across Organizations for Complex or Controversial Issues | 71.4% (15/21) | 60.0% (39/65) | 11.4% | −12.6%, | 30.5% |
|
| |||||
| Diversion of Human Resources | 68.0% (17/25) | 75.4% (46/61) | −7.4% | −29%, | 11.7% |
| Diversion of Funding Resources | 66.7% (16/24) | 85.5% (53/62) | −18.8% | −39.9%, | 0.0% |
| Diversion from Organization's Research Mandate | 65.2% (15/23) | 61.3% (38/62) | 3.9% | −19.3%, | 24.2% |
| Perceived Delays in Working Across Organizations | 73.9% (17/23) | 68.8% (44/64) | 5.1% | −17.6%, | 23.4% |
|
| 76.7% (23/30) | 89.6% (60/67) | −12.9% | −31.3%, | 2.1% |
*Percentages rounded to 1st decimal point.